SYNAGEVA BIOPHARMA CORP's ticker is and the CUSIP is 87159A903. A total of 2 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,092,000 | +40.2% | 11,200 | +33.3% | 0.00% | 0.0% |
| Q4 2014 | $779,000 | +131.2% | 8,400 | +71.4% | 0.00% | – |
| Q3 2014 | $337,000 | -78.3% | 4,900 | -66.9% | 0.00% | -100.0% |
| Q2 2014 | $1,551,000 | -16.2% | 14,800 | -33.6% | 0.00% | 0.0% |
| Q1 2014 | $1,850,000 | +449.0% | 22,300 | +328.8% | 0.00% | – |
| Q4 2013 | $337,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|